2020-24466. Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Cerilliant Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 4, 2021. Such persons may also file a written request for a hearing on the application on or before January 4, 2021.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on August 6, 2020, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    3-Fluoro-N-methylcathinone (3-FMC)1233I
    Cathinone1235I
    Methcathinone1237I
    4-Fluoro-N-methylcathinone (4-FMC)1238I
    Pentedrone (α-methylaminovalerophenone)1246I
    Mephedrone (4-Methyl-N-methylcathinone)1248I
    4-Methyl-N-ethylcathinone (4-MEC)1249I
    Naphyrone1258I
    Start Printed Page 70191
    N-Ethylamphetamine1475I
    N,N-Dimethylamphetamine1480I
    Fenethylline1503I
    Aminorex1585I
    4-Methylaminorex (cis isomer)1590I
    Gamma Hydroxybutyric Acid2010I
    Methaqualone2565I
    JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole)6250I
    SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole)7008I
    ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)7010I
    5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone7011I
    AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)7012I
    FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone)7014I
    JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)7019I
    MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)7020I
    FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate)7021I
    AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)7023I
    THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone)7024I
    5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide)7025I
    AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)7031I
    MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)7032I
    5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate)7033I
    5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)7034I
    ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)7035I
    5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)7036I
    5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)7041I
    MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)7042I
    MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate)7044I
    FUB-AKB48, FUB-APINACA, AKB48 N-(4-FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboximide)7047I
    APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide)7048I
    5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide)7049I
    JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)indole)7081I
    5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide)7083I
    5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide)7085I
    4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide)7089I
    SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl]indole)7104I
    JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)7118I
    JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole)7122I
    UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone7144I
    JWH-073 (1-Butyl-3-(1-naphthoyl)indole)7173I
    JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole)7200I
    AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole)7201I
    JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole)7203I
    NM2201, CBL2201 (Naphthalen-1-yl1-(5-fluoropentyl)-1H-indole-3-carboxylate7221I
    PB-22 (Quinolin-8-yl1-pentyl-1H-indole-3-carboxylate)7222I
    5F-PB-22 (Quinolin-8-yl1-(5-fluoropentyl)-1H-indole-3-carboxylate)7225I
    4-MEAP (4-Methyl-alpha-ethylaminopentiophenone)7245I
    N-Ethylhexedrone7246I
    Alpha-ethyltryptamine7249I
    CP-47, 497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol)7297I
    CP-47, 497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol)7298I
    Lysergic acid diethylamide7315I
    2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine7348I
    Marihuana7360I
    Tetrahydrocannabinols7370I
    Parahexyl7374I
    Mescaline7381I
    2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine)7385I
    3,4,5-Trimethoxyamphetamine7390I
    4-Bromo-2,5-dimethoxyamphetamine7391I
    4-Bromo-2,5-dimethoxyphenethylamine7392I
    4-Methyl-2,5-dimethoxyamphetamine7395I
    2,5-Dimethoxyamphetamine7396I
    JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole)7398I
    2,5-Dimethoxy-4-ethylamphetamine7399I
    3,4-Methylenedioxyamphetamine7400I
    5-Methoxy-3,4-methylenedioxyamphetamine7401I
    N-Hydroxy-3,4-methylenedioxyamphetamine7402I
    3,4-Methylenedioxy-N-ethylamphetamine7404I
    3,4-Methylenedioxymethamphetamine7405I
    Start Printed Page 70192
    4-Methoxyamphetamine7411I
    5-Methoxy-N-N-dimethyltryptamine7431I
    Alpha-methyltryptamine7432I
    Bufotenine7433I
    Diethyltryptamine7434I
    Dimethyltryptamine7435I
    Psilocybin7437I
    Psilocyn7438I
    5-Methoxy-N,N-diisopropyltryptamine7439I
    4′-Chloro-alpha-pyrrolidinovalerophenone7443I
    MPHP, 4′-Methyl-alpha-pyrrolidinohexiophenone7446I
    N-Ethyl-1-phenylcyclohexylamine7455I
    1-(1-Phenylcyclohexyl)pyrrolidine7458I
    1-[1-(2-Thienyl)cyclohexyl]piperidine7470I
    N-Benzylpiperazine7493I
    4-MePPP (4-Methyl-alphapyrrolidinopropiophenone)7498I
    2C-D (2-(2,5-Dimethoxy-4-methylphenyl)ethanamine)7508I
    2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine)7509I
    2C-H 2-(2,5-Dimethoxyphenyl)ethanamine)7517I
    2C-I 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine)7518I
    2C-C 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine)7519I
    2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine)7521I
    2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine)7524I
    2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl)ethanamine)7532I
    MDPV (3,4-Methylenedioxypyrovalerone)7535I
    25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine)7536I
    25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine)7537I
    25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine)7538I
    Methylone (3,4-Methylenedioxy-N-methylcathinone)7540I
    Butylone7541I
    Pentylone7542I
    N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one)7543I
    α-PHP, alpha-Pyrrolidinohexanophenone7544I
    alpha-pyrrolidinopentiophenone (α-PVP)7545I
    alpha-pyrrolidinobutiophenone (α-PBP)7546I
    Ethylone7547I
    PV8, alpha-Pyrrolidinoheptaphenone7548I
    AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole)7694I
    Acetyldihydrocodeine9051I
    Benzylmorphine9052I
    Codeine-N-oxide9053I
    Desomorphine9055I
    Codeine methylbromide9070I
    Dihydromorphine9145I
    Heroin9200I
    Hydromorphinol9301I
    Methyldesorphine9302I
    Methyldihydromorphine9304I
    Morphine methylbromide9305I
    Morphine methylsulfonate9306I
    Morphine-N-oxide9307I
    Normorphine9313I
    Pholcodine9314I
    U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)9547I
    AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide))9551I
    MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine))9560I
    Acetylmethadol9601I
    Allylprodine9602I
    Alphacetylmethadol except levo-alphacetylmethadol9603I
    Alphameprodine9604I
    Alphamethadol9605I
    Betacetylmethadol9607I
    Betameprodine9608I
    Betamethadol9609I
    Betaprodine9611I
    Isotonitazene9614I
    Dipipanone9622I
    Hydroxypethidine9627I
    Noracymethadol9633I
    Norlevorphanol9634I
    Normethadone9635I
    Trimeperidine9646I
    Phenomorphan9647I
    1-Methyl-4-phenyl-4-propionoxypiperidine9661I
    Start Printed Page 70193
    Tilidine9750I
    Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide)9811I
    Para-Fluorofentanyl9812I
    3-Methylfentanyl9813I
    Alpha-methylfentanyl9814I
    Acetyl-alpha-methylfentanyl9815I
    N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide9816I
    Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)9821I
    Butyryl Fentanyl9822I
    Para-fluorobutyryl fentanyl9823I
    4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)9824I
    2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide9825I
    Para-chloroisobutyryl fentanyl9826I
    Isobutyryl fentanyl9827I
    Beta-hydroxyfentanyl9830I
    Beta-hydroxy-3-methylfentanyl9831I
    Alpha-methylthiofentanyl9832I
    3-Methylthiofentanyl9833I
    Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)9834I
    Thiofentanyl9835I
    Beta-hydroxythiofentanyl9836I
    Para-methoxybutyryl fentanyl9837I
    Ocfentanil9838I
    Valeryl fentanyl9840I
    N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide9843I
    Cyclopropyl Fentanyl9845I
    Cyclopentyl fentanyl9847I
    Fentanyl related-compounds as defined in 21 CFR 1308.11(h)9850I
    8Amphetamine1100II
    Methamphetamine1105II
    Lisdexamfetamine1205II
    Phenmetrazine1631II
    Methylphenidate1724II
    Amobarbital2125II
    Pentobarbital2270II
    Secobarbital2315II
    Glutethimide2550II
    Nabilone7379II
    1-Phenylcyclohexylamine7460II
    Phencyclidine7471II
    ANPP (4-Anilino-N-phenethyl-4-piperidine)8333II
    Norfentanyl8366II
    1-Piperidinocyclohexanecarbonitrile8603II
    Alphaprodine9010II
    Cocaine9041II
    Codeine9050II
    Dihydrocodeine9120II
    Oxycodone9143II
    Hydromorphone9150II
    Diphenoxylate9170II
    Ecgonine9180II
    Ethylmorphine9190II
    Hydrocodone9193II
    Levomethorphan9210II
    Levorphanol9220II
    Isomethadone9226II
    Meperidine9230II
    Meperidine intermediate-A9232II
    Meperidine intermediate-B9233II
    Meperidine intermediate-C9234II
    Metazocine9240II
    Methadone9250II
    Methadone intermediate9254II
    Dextropropoxyphene, bulk (non-dosage forms)9273II
    Morphine9300II
    Thebaine9333II
    Levo-alphacetylmethadol9648II
    Oxymorphone9652II
    Noroxymorphone9668II
    Thiafentanil9729II
    Racemethorphan9732II
    Alfentanil9737II
    Remifentanil9739II
    Sufentanil9740II
    Start Printed Page 70194
    Carfentanil9743II
    Tapentadol9780II
    Fentanyl9801II

    The company plans to bulk manufacture small quantities of the listed controlled substances to make reference standards which will be distributed to its customers. No other activity for these drug codes is authorized for this registration.

    Start Signature

    William T. McDermott,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2020-24466 Filed 11-3-20; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
11/04/2020
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2020-24466
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 4, 2021. Such persons may also file a written request for a hearing on the application on or before January 4, 2021.
Pages:
70190-70194 (5 pages)
Docket Numbers:
Docket No. DEA-717
PDF File:
2020-24466.pdf